Hawaii 2024 Regular Session

Hawaii Senate Bill SB693

Introduced
1/20/23  
Refer
1/25/23  
Introduced
1/20/23  
Report Pass
2/17/23  
Refer
1/25/23  
Report Pass
2/17/23  
Report Pass
3/3/23  
Refer
2/17/23  
Engrossed
3/7/23  
Report Pass
3/3/23  
Refer
3/9/23  
Engrossed
3/7/23  
Refer
3/9/23  
Report Pass
3/17/23  
Report Pass
3/17/23  
Refer
3/17/23  
Report Pass
3/24/23  
Report Pass
3/24/23  
Report Pass
4/6/23  
Refer
3/24/23  

Caption

Relating To Pharmacists.

Impact

If enacted, SB 693 would facilitate a shift in state healthcare delivery by recognizing pharmacists as valuable contributors to patient care, especially in light of the physician shortage. The assessment is crucial in determining how reimbursing pharmacists for specific services could ease the burden on the healthcare system and improve access for patients. The results of the auditor's report may lead to legislative changes that could redefine the role of pharmacists in managing patient health and medication therapy, potentially leading to more efficient use of healthcare resources.

Summary

Senate Bill 693 aims to address the statewide shortage of physicians in Hawaii by exploring the potential for registered pharmacists to offer certain healthcare services that would be eligible for health insurance coverage. The bill mandates an assessment by the auditor to evaluate the social and financial implications of requiring health insurance reimbursement for healthcare services provided by pharmacists. This initiative is particularly relevant in medically underserved areas where access to physicians is limited. By leveraging pharmacists' expertise in medication management and patient education, the legislation seeks to enhance patient care and improve health outcomes.

Sentiment

The sentiment around SB 693 appears to be generally positive, with support centered on the need to address the physician shortage and enhance healthcare access. Legislators and stakeholders have acknowledged the vital role that pharmacists can play in filling gaps in patient care. However, there may be concerns regarding the implications of expanded responsibilities for pharmacists and how that may affect the traditional roles within the healthcare landscape. The bill is likely to bolster discussions around innovative solutions to workforce shortages in healthcare.

Contention

Notably, there may be contention surrounding the plan to authorize insurance reimbursements for pharmacists. Some stakeholders might argue that this could lead to an overlap with the roles of physicians or question the effectiveness of care provided by pharmacists compared to traditional providers. Additionally, the assessment could reveal varying perspectives on the social implications of such a policy, particularly concerning the financial impact on insurers and healthcare systems. Ensuring that the roles of healthcare providers are distinct yet complementary will be a key point of discussion as the bill progresses.

Companion Bills

HI SB693

Carry Over Relating To Pharmacists.

Similar Bills

HI HB2553

Relating To Pharmacists.

CA AB1589

Pharmacy: pharmacist supervision: technicians.

CA AB602

False advertising: pregnancy-related services.

WI AB173

Regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)

WI SB203

Regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)

CA SB476

Pharmacy: Pharmacist Employer Advisory Task Force.

CA SB1264

Medi-Cal: hypertension medication management services.

HI SB1245

Relating To Pharmacists.